chr1:230826522:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr1:230,826,522-230,881,322 |
| hg38 | chr1:230,690,776-230,745,576 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.003 | squamous cell carcinoma | NA | BeFree,GAD | Detail | |
| 0.002 | Low Cardiac Output | NA | GAD | Detail | |
| 0.120 | Cardiomyopathy, Alcoholic | NA | CTD_human | Detail | |
| 0.081 | Cardiomyopathy, Dilated | NA | BeFree,RGD | Detail | |
| 0.007 | hypertrophic cardiomyopathy | NA | BeFree,GAD | Detail | |
| 0.162 | Cardiovascular Diseases | This novel insight into the molecular mechanism underlying Ang-(1-7) and AngII i... | BeFree,CTD_human,GAD,LHGDN | 25225013 | Detail |
| 0.127 | Carotid Artery Diseases | NA | CTD_human,GAD | Detail | |
| 0.005 | carotid stenosis | NA | GAD | Detail | |
| 0.120 | Catalepsy | NA | CTD_human | Detail | |
| <0.001 | intracranial aneurysm | The combination of Sox17 deficiency and angiotensin II infusion in mice induces ... | BeFree | 25596186 | Detail |
| 0.005 | intracranial arteriosclerosis | NA | GAD | Detail | |
| 0.011 | cerebral infarction | NA | BeFree,GAD,LHGDN | Detail | |
| 0.014 | brain ischemia | NA | GAD | Detail | |
| 0.080 | Transient ischemic attack | NA | RGD | Detail | |
| 0.002 | cerebral palsy | NA | GAD | Detail | |
| 0.009 | Cerebrovascular Disorders | NA | GAD | Detail | |
| <0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
| 0.002 | chorioamnionitis | NA | GAD | Detail | |
| <0.001 | choriocarcinoma | NA | BeFree | Detail | |
| 0.005 | Chromosome Deletion | NA | GAD | Detail | |
| <0.001 | colorectal carcinoma | Role of two types of angiotensin II receptors in colorectal carcinoma progressio... | BeFree | 25138435 | Detail |
| 0.002 | Connective Tissue Diseases | NA | GAD | Detail | |
| 0.026 | Coronary Arteriosclerosis | NA | BeFree,GAD | Detail | |
| 0.045 | Coronary heart disease | Disease association analysis revealed that haplotype AGT influences CHD risk (OR... | BeFree,GAD,LHGDN | 24965144 | Detail |
| 0.002 | coronary thrombosis | NA | GAD | Detail | |
| <0.001 | Crohn Disease | NA | BeFree | Detail | |
| <0.001 | Cyst | Renal function in angiotensinogen gene-mutated renal tubular dysgenesis with glo... | BeFree | 25414114 | Detail |
| 0.002 | Deafness | NA | GAD | Detail | |
| 0.120 | Sudden death | NA | CTD_human | Detail | |
| 0.008 | Dementia, Vascular | NA | BeFree,GAD,LHGDN | Detail | |
| 0.006 | Mental Depression | NA | BeFree,GAD | Detail | |
| <0.001 | depressive disorder | NA | BeFree | Detail | |
| 0.120 | Diabetes Mellitus, Experimental | NA | CTD_human | Detail | |
| 0.016 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree,GAD | Detail | |
| 0.071 | Diabetes Mellitus, Non-Insulin-Dependent | Angiotensin II (Ang II), the major effector hormone of renin-angiotensin system,... | BeFree,GAD,LHGDN | 25430897 | Detail |
| 0.005 | Diabetic Angiopathies | NA | GAD,LHGDN | Detail | |
| 0.002 | Diabetic Neuropathies | NA | GAD | Detail | |
| 0.208 | diabetic retinopathy | NA | BeFree,CTD_human,GAD,LHGDN,RGD | Detail | |
| 0.002 | DNA Damage | NA | GAD | Detail | |
| <0.001 | duodenal ulcer | NA | BeFree | Detail | |
| <0.001 | Dwarfism | NA | BeFree | Detail | |
| 0.006 | eclampsia | NA | BeFree,GAD | Detail | |
| 0.002 | Edema | NA | GAD | Detail | |
| <0.001 | Venezuelan equine encephalomyelitis | Role of angiotensin II in experimental Venezuelan equine encephalitis in rats. | BeFree | 26156105 | Detail |
| 0.080 | Epilepsy, Temporal Lobe | NA | BeFree,RGD | Detail | |
| 0.002 | Esophageal Varices | NA | GAD | Detail | |
| 0.002 | Fatty Liver | NA | GAD | Detail | |
| 0.122 | Fetal Growth Retardation | NA | CTD_human,GAD | Detail | |
| 0.002 | Fetal Membranes, Premature Rupture | NA | GAD | Detail | |
| 0.003 | Fibromuscular Dysplasia | NA | BeFree,GAD | Detail | |
| 0.207 | Fibrosis | NA | CTD_human,GAD,LHGDN,RGD | Detail | |
| 0.002 | Gastrointestinal Diseases | NA | GAD | Detail | |
| 0.002 | Gastrointestinal Hemorrhage | NA | GAD | Detail | |
| 0.005 | glaucoma | NA | BeFree,GAD | Detail | |
| <0.001 | Glaucoma, Open-Angle | NA | BeFree | Detail | |
| <0.001 | glioblastoma | NA | BeFree | Detail | |
| 0.124 | glomerulonephritis | NA | BeFree,CTD_human,GAD | Detail | |
| 0.160 | IgA glomerulonephritis | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| <0.001 | membranous glomerulonephritis | NA | BeFree | Detail | |
| 0.204 | Focal glomerulosclerosis | Angiotensin II, acting through its AT1 receptor, plays a critical role in genera... | BeFree,CTD_human,LHGDN,RGD | 26551740 | Detail |
| <0.001 | Glycogen storage disease type II | DNA was extracted and tested for GAA mutations and some genetic polymorphisms ab... | BeFree | 25103075 | Detail |
| 0.002 | Graft-vs-Host Disease | NA | GAD | Detail | |
| 0.002 | Hearing Loss, Partial | NA | GAD | Detail | |
| <0.001 | Sensorineural Hearing Loss (disorder) | Furthermore, the AGT and GAC haplotypes were associated with a significantly hig... | BeFree | 26051414 | Detail |
| 0.002 | congenital heart defects | NA | GAD | Detail | |
| 0.124 | Heart Diseases | NA | BeFree,CTD_human,LHGDN | Detail | |
| 0.200 | Cardiomegaly | NA | CTD_human,RGD | Detail | |
| 0.217 | Heart failure | The M235T polymorphism in the angiotensinogen gene and heart failure: a meta-ana... | BeFree,CTD_human,GAD,RGD | 23154270 | Detail |
| 0.217 | Heart failure | The angiotensinogen gene polymorphism is associated with heart failure among Asi... | BeFree,CTD_human,GAD,RGD | 24572548 | Detail |
| 0.217 | Heart failure | Refractory hyperaldosteronism in heart failure is associated with plasma renin a... | BeFree,CTD_human,GAD,RGD | 25036270 | Detail |
| 0.009 | congestive heart failure | The M235T polymorphism in the angiotensinogen gene and heart failure: a meta-ana... | BeFree | 23154270 | Detail |
| 0.009 | congestive heart failure | The angiotensinogen gene polymorphism is associated with heart failure among Asi... | BeFree | 24572548 | Detail |
| 0.009 | congestive heart failure | Refractory hyperaldosteronism in heart failure is associated with plasma renin a... | BeFree | 25036270 | Detail |
| <0.001 | Myocardial rupture | NA | BeFree | Detail | |
| 0.002 | hemochromatosis | NA | GAD | Detail | |
| 0.002 | hemolytic-uremic syndrome | NA | GAD | Detail | |
| 0.002 | Hemorrhage | NA | GAD | Detail | |
| <0.001 | hepatitis | NA | BeFree | Detail | |
| <0.001 | hepatitis A | NA | BeFree | Detail | |
| <0.001 | hepatitis B | DNA vaccines have also been designed via a similar strategy using a plasmid vect... | BeFree | 25673364 | Detail |
| <0.001 | Hepatitis, Chronic | NA | BeFree | Detail | |
| 0.006 | hepatitis C | NA | BeFree,GAD | Detail | |
| 0.123 | Diaphragmatic hernia | NA | CTD_human,LHGDN | Detail | |
| 0.001 | Hyperaldosteronism | Refractory hyperaldosteronism in heart failure is associated with plasma renin a... | BeFree | 25036270 | Detail |
| 0.120 | Hyperalgesia | NA | CTD_human | Detail | |
| 0.006 | Hypercholesterolemia | NA | BeFree,GAD,LHGDN | Detail | |
| 0.010 | Hypercholesterolemia, Familial | NA | BeFree,GAD,LHGDN | Detail | |
| 0.120 | Hyperemia | NA | CTD_human | Detail | |
| <0.001 | hyperglycemia | NA | BeFree | Detail | |
| <0.001 | hyperinsulinism | NA | BeFree | Detail | |
| 0.005 | Hyperlipidemia | NA | BeFree,GAD | Detail | |
| <0.001 | Hypernatremia | NA | BeFree | Detail | |
| <0.001 | primary hyperoxaluria | NA | BeFree | Detail | |
| 0.440 | Hypertensive disease | The AGT-6A and 4072C alleles are associated with susceptibility to hypertension ... | BeFree,CTD_human,GAD,LHGDN,RGD | 23716723 | Detail |
| 0.440 | Hypertensive disease | Gβ3-deficient mice were normal as judged by body weight gain by age or by feedin... | BeFree,CTD_human,GAD,LHGDN,RGD | 25093805 | Detail |
| 0.440 | Hypertensive disease | Increased association of hypertension and TT angiotensinogen gene polymorphism i... | BeFree,CTD_human,GAD,LHGDN,RGD | 25109108 | Detail |
| 0.440 | Hypertensive disease | In summary, PRO20 binds to both mouse and human PRRs and decreases angiotensin I... | BeFree,CTD_human,GAD,LHGDN,RGD | 25421983 | Detail |
| 0.440 | Hypertensive disease | Over-expression of copper/zinc superoxide dismutase in the median preoptic nucle... | BeFree,CTD_human,GAD,LHGDN,RGD | 25474089 | Detail |
| 0.440 | Hypertensive disease | We isolated transgenic BMSCs (TG-BMSCs) from young end-organ-disease-free rats w... | BeFree,CTD_human,GAD,LHGDN,RGD | 25534858 | Detail |
| 0.440 | Hypertensive disease | The vaccine-induced anti-angiotensin II antibodies can efficiently ameliorate hi... | BeFree,CTD_human,GAD,LHGDN,RGD | 25673364 | Detail |
| 0.440 | Hypertensive disease | The mechanism of hypertension-induced renal fibrosis is not well understood, alt... | BeFree,CTD_human,GAD,LHGDN,RGD | 25945342 | Detail |
| 0.440 | Hypertensive disease | AGT, ACE, and AT 1 R genes have overall effects with susceptibility to hypertens... | BeFree,CTD_human,GAD,LHGDN,RGD | 25961019 | Detail |
| 0.124 | malignant hypertension | NA | BeFree,CTD_human,LHGDN | Detail | |
| <0.001 | Hypertension, Portal | NA | BeFree | Detail | |
| 0.085 | pulmonary hypertension | NA | BeFree,GAD,LHGDN,RGD | Detail | |
| 0.127 | renal hypertension | NA | CTD_human,GAD | Detail | |
| <0.001 | Hypertension, Renovascular | NA | BeFree | Detail | |
| 0.003 | hypoglycemia | NA | BeFree,GAD | Detail | |
| 0.120 | hypokalemia | NA | CTD_human | Detail | |
| 0.120 | Hypotension | NA | CTD_human | Detail | |
| 0.003 | Hypotension, Orthostatic | NA | LHGDN | Detail | |
| 0.005 | Infarction | NA | LHGDN | Detail | |
| 0.122 | Inflammation | NA | CTD_human,GAD | Detail | |
| <0.001 | Inflammatory Bowel Diseases | NA | BeFree | Detail | |
| 0.005 | Insulin resistance | NA | GAD | Detail | |
| 0.001 | ischemia | NA | BeFree | Detail | |
| <0.001 | Keloid | NA | BeFree | Detail | |
| 0.003 | Kidney Failure, Acute | NA | BeFree,GAD | Detail | |
| 0.005 | Polycystic Kidney Diseases | NA | BeFree,GAD | Detail | |
| 0.002 | Premature Obstetric Labor | NA | GAD | Detail | |
| 0.002 | Hyperlipoproteinemia Type I | NA | GAD | Detail | |
| 0.218 | liver cirrhosis | NA | BeFree,CTD_human,GAD,LHGDN,RGD | Detail | |
| 0.002 | Liver Cirrhosis, Alcoholic | NA | GAD | Detail | |
| 0.080 | Biliary cirrhosis | NA | RGD | Detail | |
| 0.120 | Liver Cirrhosis, Experimental | NA | CTD_human | Detail | |
| 0.003 | Liver diseases | NA | BeFree,GAD | Detail | |
| 0.002 | Alcoholic Liver Diseases | NA | GAD | Detail | |
| 0.001 | Liver neoplasms | NA | BeFree | Detail | |
| 0.002 | long QT syndrome | NA | GAD | Detail | |
| 0.002 | Chronic Obstructive Airway Disease | NA | GAD | Detail | |
| 0.003 | Lupus Erythematosus, Systemic | NA | BeFree,GAD | Detail | |
| 0.005 | lupus nephritis | NA | BeFree,GAD | Detail | |
| 0.171 | essential hypertension | Tailed allele-specific primers were designed to amplify by PCR six biallelic SNP... | BeFree | 12446468 | Detail |
| <0.001 | malaria | NA | BeFree | Detail | |
| <0.001 | Malaria, Cerebral | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of stomach | NA | BeFree | Detail | |
| 0.002 | Animal Mammary Neoplasms | NA | GAD | Detail | |
| 0.080 | Mammary Neoplasms, Experimental | NA | RGD | Detail | |
| 0.003 | Marfan syndrome | NA | BeFree,GAD | Detail | |
| <0.001 | melanoma | NA | BeFree | Detail | |
| 0.002 | Meningococcal Infections | NA | GAD | Detail | |
| <0.001 | Metabolic Diseases | NA | BeFree | Detail | |
| <0.001 | mitral valve insufficiency | The tissue concentrations of angiotensin II and gene expression of hypertrophic ... | BeFree | 25500755 | Detail |
| 0.008 | Mitral Valve Prolapse Syndrome | NA | BeFree,GAD | Detail | |
| <0.001 | mitral valve stenosis | NA | BeFree | Detail | |
| 0.002 | Mouth Neoplasms | NA | GAD | Detail | |
| 0.004 | multiple sclerosis | NA | BeFree,LHGDN | Detail | |
| <0.001 | muscular atrophy | NA | BeFree | Detail | |
| 0.247 | myocardial infarction | Anterior wall infarction, increased leucocyte count, decreased longitudinal stra... | BeFree,CTD_human,GAD,LHGDN,RGD | 23283822 | Detail |
| 0.247 | myocardial infarction | The M235T polymorphism in the angiotensinogen gene and myocardial infarction ris... | BeFree,CTD_human,GAD,LHGDN,RGD | 23283824 | Detail |
| 0.120 | Myocardial Reperfusion Injury | NA | CTD_human | Detail | |
| 0.120 | Necrosis | NA | CTD_human | Detail | |
| 0.001 | Neoplasm Metastasis | Angiotensin II (Ang-II) is a bioactive peptide associated closely with the progr... | BeFree | 25138435 | Detail |
| 0.003 | Nephritis, Interstitial | NA | BeFree,GAD | Detail | |
| <0.001 | nephrosclerosis | NA | BeFree | Detail | |
| 0.120 | nephrosis | NA | CTD_human | Detail | |
| 0.008 | nephrotic syndrome | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | neuroblastoma | NA | BeFree | Detail | |
| 0.024 | obesity | NA | BeFree,GAD | Detail | |
| 0.002 | Obesity, Morbid | NA | GAD | Detail | |
| <0.001 | osteoporosis | NA | BeFree | Detail | |
| 0.003 | otosclerosis | NA | BeFree,GAD | Detail | |
| <0.001 | ovarian carcinoma | NA | BeFree | Detail | |
| <0.001 | Ovarian Diseases | NA | BeFree | Detail | |
| 0.120 | Drug Overdose | NA | CTD_human | Detail | |
| <0.001 | panic disorder | NA | BeFree | Detail | |
| 0.003 | Chronic glomerulonephritis | We evaluate whether angiotensinogen AGT M235T (rs699), angiotensin-converting en... | BeFree | 23681285 | Detail |
| 0.002 | Peptic Ulcer | NA | GAD | Detail | |
| 0.122 | Peptic Ulcer Hemorrhage | NA | CTD_human,GAD | Detail | |
| 0.003 | periodontitis | NA | BeFree,GAD | Detail | |
| <0.001 | Peutz-Jeghers syndrome | NA | BeFree | Detail | |
| <0.001 | pheochromocytoma | NA | BeFree | Detail | |
| <0.001 | Pituitary Diseases | NA | BeFree | Detail | |
| 0.002 | Placenta Disorders | NA | GAD | Detail | |
| 0.006 | polycystic ovary syndrome | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Postoperative Complications | NA | GAD | Detail | |
| 0.171 | pre-eclampsia | NA | CTD_human,GAD,LHGDN | Detail | |
| 0.003 | Pregnancy Complications | NA | BeFree,GAD | Detail | |
| 0.005 | Pregnancy Complications, Cardiovascular | NA | GAD | Detail | |
| 0.002 | Prostatic Neoplasms | NA | GAD | Detail | |
| 0.129 | proteinuria | NA | CTD_human,GAD | Detail | |
| <0.001 | pterygium | Angiotensin II: immunohistochemical study in Sardinian pterygium. | BeFree | 25308851 | Detail |
| <0.001 | pulmonary fibrosis | NA | BeFree | Detail | |
| 0.003 | purpura | NA | LHGDN | Detail | |
| 0.003 | Henoch-Schoenlein purpura | To evaluate the association between angiotensinogen (AGT) gene polymorphism and ... | BeFree,GAD | 25350836 | Detail |
| 0.002 | renal artery obstruction | NA | GAD | Detail | |
| <0.001 | Renal Artery Stenosis | NA | BeFree | Detail | |
| 0.010 | kidney failure | We isolated transgenic BMSCs (TG-BMSCs) from young end-organ-disease-free rats w... | BeFree,GAD | 25534858 | Detail |
| 0.120 | Reperfusion Injury | NA | CTD_human | Detail | |
| 0.003 | Respiratory Distress Syndrome, Adult | NA | BeFree,GAD | Detail | |
| 0.003 | Retinal Diseases | NA | BeFree,GAD | Detail | |
| 0.120 | retinopathy of prematurity | NA | CTD_human | Detail | |
| 0.002 | rheumatic heart disease | NA | GAD | Detail | |
| <0.001 | sarcoidosis | NA | BeFree | Detail | |
| <0.001 | systemic scleroderma | NA | BeFree | Detail | |
| 0.120 | Seizures | NA | BeFree,CTD_human | Detail | |
| <0.001 | Septicemia | NA | BeFree | Detail | |
| 0.003 | Sleep Apnea Syndromes | NA | BeFree,GAD | Detail | |
| 0.005 | Stomach Neoplasms | NA | GAD,LHGDN | Detail | |
| 0.028 | Cerebrovascular accident | In addition to the CHADS2 score, angiotensinogen gene polymorphisms may be consi... | BeFree,GAD,LHGDN | 24732371 | Detail |
| <0.001 | Subarachnoid Hemorrhage | The combination of Sox17 deficiency and angiotensin II infusion in mice induces ... | BeFree | 25596186 | Detail |
| <0.001 | Tachycardia | NA | BeFree | Detail | |
| 0.120 | thrombosis | NA | CTD_human | Detail | |
| <0.001 | Turner syndrome | NA | BeFree | Detail | |
| 0.003 | uremia | NA | BeFree,GAD | Detail | |
| <0.001 | ureteral obstruction | NA | BeFree | Detail | |
| 0.005 | Vascular Diseases | NA | BeFree,GAD | Detail | |
| 0.005 | Vasovagal syncope | NA | GAD | Detail | |
| 0.005 | Venous Thrombosis | NA | GAD,LHGDN | Detail | |
| 0.003 | Tachycardia, Ventricular | NA | LHGDN | Detail | |
| 0.006 | Vesico-Ureteral Reflux | NA | BeFree,GAD | Detail | |
| <0.001 | viral hepatitis | NA | BeFree | Detail | |
| 0.002 | Helicobacter Infections | NA | GAD | Detail | |
| 0.005 | Peripheral Vascular Diseases | NA | BeFree,GAD | Detail | |
| <0.001 | Ovarian Failure, Premature | NA | BeFree | Detail | |
| 0.002 | Sudden cardiac death | NA | GAD | Detail | |
| 0.001 | Polycystic Kidney, Autosomal Dominant | NA | BeFree | Detail | |
| 0.171 | essential hypertension | The relationship between angiotensinogen gene polymorphisms and essential hypert... | BeFree,CTD_human,GAD | 23716723 | Detail |
| 0.171 | essential hypertension | Risk conferred by tagged SNPs of AGT gene in causing susceptibility to essential... | BeFree,CTD_human,GAD | 24490766 | Detail |
| 0.171 | essential hypertension | The polymorphic angiotensinogen (AGT) gene is one of the most promising candidat... | BeFree,CTD_human,GAD | 25143324 | Detail |
| 0.171 | essential hypertension | ACE I/D, AGT M235T, and ADD Gly460Trp polymorphisms are thought to be associated... | BeFree,CTD_human,GAD | 25262176 | Detail |
| 0.174 | Left Ventricular Hypertrophy | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| 0.003 | Migraine Disorders | NA | BeFree,GAD | Detail | |
| <0.001 | obstructive nephropathy | NA | BeFree | Detail | |
| 0.080 | sciatic neuropathy | NA | RGD | Detail | |
| 0.005 | Premature Birth | NA | GAD | Detail | |
| 0.003 | renal fibrosis | Clusterin/apolipoprotein J attenuates angiotensin II-induced renal fibrosis. | BeFree | 25148511 | Detail |
| 0.003 | renal fibrosis | The mechanism of hypertension-induced renal fibrosis is not well understood, alt... | BeFree | 25945342 | Detail |
| 0.135 | Myocardial Ischemia | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| <0.001 | hypertensive heart disease | NA | BeFree | Detail | |
| 0.003 | Chronic glomerulonephritis | We evaluate whether angiotensinogen AGT M235T (rs699), angiotensin-converting en... | BeFree,GAD | 23681285 | Detail |
| <0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
| <0.001 | migraine with aura | NA | BeFree | Detail | |
| <0.001 | secondary hypertension | We suggest that RAS gene polymorphisms (ACE-I/D, AGT M235T) are significantly as... | BeFree | 25262176 | Detail |
| 0.002 | acute myocardial infarction | Left ventricular remodelling after acute myocardial infarction: impact of clinic... | BeFree | 23283822 | Detail |
| <0.001 | Atherosclerosis of aorta | NA | BeFree | Detail | |
| <0.001 | Disease of capillaries | NA | BeFree | Detail | |
| <0.001 | Chronic hypotension | NA | BeFree | Detail | |
| 0.127 | Aortic Aneurysm, Abdominal | Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin ... | BeFree,CTD_human,GAD | 25301841 | Detail |
| 0.127 | Aortic Aneurysm, Abdominal | Peroxisome proliferator-activated receptor x03B3; agonists have been shown to in... | BeFree,CTD_human,GAD | 26113112 | Detail |
| 0.003 | Aortic Aneurysm, Thoracic | Using a loss-of-function genetic mouse model, we demonstrated that the lack of M... | BeFree,GAD | 25963716 | Detail |
| <0.001 | Agenesis of corpus callosum | NA | BeFree | Detail | |
| 0.003 | Glomerulosclerosis (disorder) | NA | BeFree | Detail | |
| <0.001 | Tumor Progression | NA | BeFree | Detail | |
| <0.001 | adrenal cortical adenoma | NA | BeFree | Detail | |
| <0.001 | adrenocortical carcinoma | NA | BeFree | Detail | |
| <0.001 | Cervical Intraepithelial Neoplasia | NA | BeFree | Detail | |
| <0.001 | Liddle syndrome | NA | BeFree | Detail | |
| <0.001 | Systolic hypertension | NA | BeFree | Detail | |
| <0.001 | Lesion of brain | NA | BeFree | Detail | |
| 0.001 | Fibrillation | Genotyping of the angiotensinogen gene is helpful to determine which AF patients... | BeFree | 24732371 | Detail |
| <0.001 | Diastolic hypertension | NA | BeFree | Detail | |
| 0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| <0.001 | Renal interstitial fibrosis | NA | BeFree | Detail | |
| <0.001 | Congenital posterior urethral valves | NA | BeFree | Detail | |
| 0.002 | Fibrosis, Liver | NA | BeFree | Detail | |
| <0.001 | Interstitial fibrosis | NA | BeFree | Detail | |
| <0.001 | Thrombotic stroke | NA | BeFree | Detail | |
| 0.005 | coronary stenosis | NA | BeFree,GAD | Detail | |
| 0.003 | Dyslipidemias | NA | BeFree,GAD | Detail | |
| 0.080 | Erectile dysfunction | NA | RGD | Detail | |
| 0.003 | Malignant neoplasm of lung | Genetic Association Between Angiotensinogen Polymorphisms and Lung Cancer Risk. | BeFree,GAD | 26376373 | Detail |
| 0.005 | age related macular degeneration | NA | GAD | Detail | |
| <0.001 | Drug usage | NA | BeFree | Detail | |
| 0.002 | Ventricular Dysfunction, Left | NA | GAD | Detail | |
| <0.001 | Sepsis | NA | BeFree | Detail | |
| <0.001 | Cardiovascular Abnormalities | NA | BeFree | Detail | |
| <0.001 | Low-renin essential hypertension | NA | BeFree | Detail | |
| <0.001 | Endocrine hypertension | NA | BeFree | Detail | |
| <0.001 | Hypertensive heart failure | NA | BeFree | Detail | |
| <0.001 | Chronic heart failure | NA | BeFree | Detail | |
| <0.001 | Dilatation of aorta | Homozygous deletion of Opg in apolipoprotein E-deficient mice (ApoE(-/-)Opg(-/-)... | BeFree | 25301844 | Detail |
| 0.480 | Allanson Pantzar McLeod syndrome | Renal function in angiotensinogen gene-mutated renal tubular dysgenesis with glo... | BeFree,CLINVAR,CTD_human,ORPHANET,UNIPROT | 25414114 | Detail |
| 0.003 | Chronic Periodontitis | NA | BeFree,GAD | Detail | |
| 0.002 | Primary hyperoxaluria, type I | NA | BeFree | Detail | |
| <0.001 | Renal glomerular disease | NA | BeFree | Detail | |
| 0.001 | Renal vascular disorder | NA | BeFree | Detail | |
| <0.001 | inflammatory breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
| <0.001 | Solid tumour | NA | BeFree | Detail | |
| <0.001 | Very Low Birth Weight | NA | BeFree | Detail | |
| <0.001 | cervix carcinoma | NA | BeFree | Detail | |
| <0.001 | Obesity, Abdominal | NA | BeFree | Detail | |
| 0.007 | Restenosis | The results showed that the distribution of AGT and REN polymorphisms were simil... | BeFree,GAD | 26102248 | Detail |
| <0.001 | Bleeding ulcer | NA | BeFree | Detail | |
| <0.001 | Segmental glomerulosclerosis | NA | BeFree | Detail | |
| <0.001 | Infarction, Lacunar | NA | BeFree | Detail | |
| 0.042 | coronary artery disease | Four polymorphisms, located in the ACE (rs4291), angiotensinogen (rs5049) and (p... | BeFree | 21157371 | Detail |
| 0.005 | Vascular Diseases | Four polymorphisms, located in the ACE (rs4291), angiotensinogen (rs5049) and (p... | BeFree | 21157371 | Detail |
| <0.001 | Ventricular hypertrophy | NA | BeFree | Detail | |
| 0.001 | Aortic aneurysm without mention of rupture NOS | In early atherosclerotic lesions, Rgs1 regulates macrophage accumulation and is ... | BeFree | 25782711 | Detail |
| <0.001 | Dissection of aorta | NA | BeFree | Detail | |
| <0.001 | Generalized glycogen storage disease of infants | DNA was extracted and tested for GAA mutations and some genetic polymorphisms ab... | BeFree | 25103075 | Detail |
| <0.001 | Left ventricular dilatation | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of liver | NA | BeFree | Detail | |
| 0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| 0.080 | prediabetes syndrome | NA | RGD | Detail | |
| <0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
| <0.001 | Hereditary hemochromatosis | NA | BeFree | Detail | |
| 0.002 | Atopy | NA | GAD | Detail | |
| 0.005 | thrombophilia | NA | GAD | Detail | |
| <0.001 | Non-alcoholic Fatty Liver Disease | NA | BeFree | Detail | |
| 0.002 | Chronic Kidney Insufficiency | NA | BeFree | Detail | |
| 0.080 | Anti-Glomerular Basement Membrane Disease | NA | RGD | Detail | |
| 0.001 | Chronic rejection of renal transplant | NA | BeFree | Detail | |
| 0.120 | Bradycardia | NA | CTD_human | Detail | |
| <0.001 | urolithiasis | NA | BeFree | Detail | |
| <0.001 | endometrial carcinoma | The evaluation of involvement of angiotensin II, its receptors, and androgen rec... | BeFree | 25231075 | Detail |
| <0.001 | Overweight | NA | BeFree | Detail | |
| 0.003 | Sleep Apnea, Obstructive | NA | LHGDN | Detail | |
| <0.001 | Granulomatosis | NA | BeFree | Detail | |
| 0.089 | Metabolic syndrome X | NA | BeFree,GAD,RGD | Detail | |
| 0.006 | Hepatitis B, Chronic | NA | BeFree,GAD,LHGDN | Detail | |
| 0.008 | Hepatitis C, Chronic | NA | BeFree,GAD | Detail | |
| <0.001 | Fluid overload | NA | BeFree | Detail | |
| 0.120 | endomyocardial fibrosis | NA | CTD_human | Detail | |
| 0.002 | Maternal hypertension | NA | BeFree | Detail | |
| 0.002 | Menopause present (finding) | NA | GAD | Detail | |
| 0.001 | Carotid Atherosclerosis | NA | BeFree | Detail | |
| <0.001 | Intraocular pressure disorder | NA | BeFree | Detail | |
| 0.002 | Carcinogenesis | Accumulating evidence suggests a role for angiotensin-converting enzymes involvi... | BeFree | 25121552 | Detail |
| <0.001 | Neurogenic hypertension | Taken together with our previous data which indicate that pro-inflammatory proce... | BeFree | 25302502 | Detail |
| <0.001 | renin induced hypertension | NA | BeFree | Detail | |
| 0.001 | genetic hypertension | NA | BeFree | Detail | |
| <0.001 | hyperhomocysteinemia | NA | BeFree | Detail | |
| 0.002 | prostate carcinoma | NA | BeFree | Detail | |
| 0.005 | breast carcinoma | Association between AT1 and AT2 angiotensin II receptor expression with cell pro... | BeFree | 25682288 | Detail |
| <0.001 | renin-dependent hypertension | NA | BeFree | Detail | |
| <0.001 | Carcinoma of lung | Genetic Association Between Angiotensinogen Polymorphisms and Lung Cancer Risk. | BeFree | 26376373 | Detail |
| <0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
| 0.002 | stomach carcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
| <0.001 | Central neuroblastoma | NA | BeFree | Detail | |
| 0.002 | Microalbuminuria | NA | BeFree | Detail | |
| 0.080 | Infarction, Middle Cerebral Artery | NA | RGD | Detail | |
| <0.001 | lymphangioleiomyomatosis | NA | BeFree | Detail | |
| 0.005 | brain infarction | NA | BeFree,GAD | Detail | |
| 0.081 | hypertensive nephropathy | NA | BeFree,RGD | Detail | |
| <0.001 | Helicobacter pylori infection | NA | BeFree | Detail | |
| 0.097 | Pregnancy associated hypertension | NA | GAD,LHGDN,RGD | Detail | |
| 0.003 | Arteriopathic disease | NA | BeFree,GAD | Detail | |
| <0.001 | Oestrogen deficiency | NA | BeFree | Detail | |
| <0.001 | Diabetic Cardiomyopathies | NA | BeFree | Detail | |
| 0.003 | Endothelial dysfunction | To investigate intercellular adhesion molecule-1 (ICAM1) and angiotensinogen (AG... | BeFree | 24942509 | Detail |
| <0.001 | Chronic graft-versus-host disease | NA | BeFree | Detail | |
| <0.001 | Enzyme inhibition disorder | NA | BeFree | Detail | |
| 0.129 | Cardiomyopathies | NA | BeFree,CTD_human,GAD | Detail | |
| <0.001 | Cerebral Ischemia | NA | BeFree | Detail | |
| <0.001 | Cerebral Aneurysm | Effects of endogenous myeloperoxidase on CA formation and rupture were studied i... | BeFree | 25922506 | Detail |
| <0.001 | Renal ischaemia | NA | BeFree | Detail | |
| 0.002 | Vascular inflammations | Interestingly, in a model of enhanced vascular inflammation using angiotensin II... | BeFree | 25360548 | Detail |
| 0.002 | Ischemic stroke | NA | BeFree | Detail | |
| 0.005 | Acute coronary syndrome | NA | BeFree,GAD | Detail | |
| 0.002 | Leukoaraiosis | NA | GAD | Detail | |
| 0.002 | coronary restenosis | NA | GAD | Detail | |
| 0.003 | Cardiomyopathy, Hypertrophic, Familial | NA | BeFree,GAD | Detail | |
| <0.001 | Macroangiopathy | NA | BeFree | Detail | |
| 0.003 | Heart Failure, Systolic | NA | BeFree,GAD | Detail | |
| 0.005 | Heart Failure, Diastolic | NA | BeFree,GAD | Detail | |
| <0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
| <0.001 | Renal anemia | NA | BeFree | Detail | |
| <0.001 | severe acute respiratory syndrome | NA | BeFree | Detail | |
| <0.001 | glucocorticoid-remediable aldosteronism | NA | BeFree | Detail | |
| 0.002 | attention deficit hyperactivity disorder | NA | GAD | Detail | |
| 0.007 | Blood pressure finding | NA | GAD | Detail | |
| 0.021 | Systemic arterial pressure | NA | GAD | Detail | |
| <0.001 | Left ventricular systolic dysfunction | We enrolled 109 consecutive patients with left ventricular systolic dysfunction ... | BeFree | 25036270 | Detail |
| <0.001 | Multi vessel coronary artery disease | NA | BeFree | Detail | |
| <0.001 | Cauda Equina Paraganglioma | NA | BeFree | Detail | |
| <0.001 | Invasive Carcinoma | NA | BeFree | Detail | |
| <0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | Conn Syndrome | NA | BeFree | Detail | |
| 0.002 | hearing impairment | NA | GAD | Detail | |
| 0.002 | Cardiac fibrosis | NA | BeFree | Detail | |
| 0.003 | Mammary Neoplasms | NA | BeFree,GAD | Detail | |
| <0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
| <0.001 | Cancer Cell Growth | NA | BeFree | Detail | |
| <0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
| 0.003 | colorectal cancer | Angiotensin II (Ang-II) is a bioactive peptide associated closely with the progr... | BeFree,GAD | 25138435 | Detail |
| <0.001 | ST segment elevation myocardial infarction | NA | BeFree | Detail | |
| 0.004 | Chronic Kidney Diseases | NA | BeFree | Detail | |
| 0.123 | Renal Insufficiency | NA | BeFree,CTD_human,GAD | Detail | |
| <0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
| <0.001 | Cirrhosis | NA | BeFree | Detail | |
| <0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
| 0.006 | Idiopathic Pulmonary Fibrosis | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | MAJOR AFFECTIVE DISORDER 2 | NA | BeFree,GAD | Detail | |
| 0.003 | MAJOR AFFECTIVE DISORDER 1 | NA | BeFree,GAD | Detail | |
| <0.001 | ABLEPHARON-MACROSTOMIA SYNDROME | NA | BeFree | Detail | |
| 0.002 | Venous thromboembolism | NA | GAD | Detail | |
| <0.001 | PANIC DISORDER 1 | NA | BeFree | Detail | |
| <0.001 | uterine corpus cancer | The evaluation of involvement of angiotensin II, its receptors, and androgen rec... | BeFree | 25231075 | Detail |
| 0.042 | coronary artery disease | The aim of the present study was to evaluate the role of AGT and REN gene polymo... | BeFree,GAD,LHGDN | 26102248 | Detail |
| 0.009 | Proteinuria Adverse Event | NA | GAD | Detail | |
| 0.003 | MAJOR AFFECTIVE DISORDER 4 | NA | BeFree,GAD | Detail | |
| 0.003 | MAJOR AFFECTIVE DISORDER 5 | NA | BeFree,GAD | Detail | |
| 0.003 | MAJOR AFFECTIVE DISORDER 6 | NA | BeFree,GAD | Detail | |
| <0.001 | Mesial temporal sclerosis | NA | BeFree | Detail | |
| <0.001 | Influenza A/H5N1 | In experimental mouse models, infection with highly pathogenic avian influenza A... | BeFree | 24800825 | Detail |
| 0.004 | liver carcinoma | NA | BeFree | Detail | |
| 0.003 | Allergic rhinitis (disorder) | According to the analysis of the three strong positive SNPs, the haplotype of AG... | BeFree,GAD | 25594855 | Detail |
| 0.002 | Cerebral white matter lesion | NA | GAD | Detail | |
| <0.001 | Loeys-Dietz syndrome | NA | BeFree | Detail | |
| 0.003 | Major affective disorder 7 | NA | BeFree,GAD | Detail | |
| 0.003 | MAJOR AFFECTIVE DISORDER 8 | NA | BeFree,GAD | Detail | |
| 0.003 | MAJOR AFFECTIVE DISORDER 9 | NA | BeFree,GAD | Detail | |
| <0.001 | Steatohepatitis | NA | BeFree | Detail | |
| <0.001 | Acquired long QT syndrome | NA | BeFree | Detail | |
| 0.002 | Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | NA | GAD | Detail | |
| <0.001 | Crigler Najjar syndrome, type 2 | NA | BeFree | Detail | |
| <0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
| <0.001 | Obesity, Visceral | NA | BeFree | Detail | |
| 0.120 | Neointima | NA | CTD_human | Detail | |
| 0.002 | Cerebral Hemorrhage | NA | GAD | Detail | |
| 0.002 | Aortic Stiffness | NA | GAD | Detail | |
| 0.002 | Ischemic Cerebrovascular Accident | NA | BeFree | Detail | |
| <0.001 | Homocysteinemia | NA | BeFree | Detail | |
| <0.001 | granulomatosis with polyangiitis | NA | BeFree | Detail | |
| <0.001 | aortic valve disease 2 | NA | BeFree | Detail | |
| 0.002 | Hypertriglyceridemic Waist | NA | GAD | Detail | |
| <0.001 | Chronic kidney disease due to hypertension | To test our hypothesis, we used an angiotensin II infusion model of hypertensive... | BeFree | 25987665 | Detail |
| 0.002 | Hearing Loss | NA | GAD | Detail | |
| 0.010 | Abruptio Placentae | NA | GAD,LHGDN | Detail | |
| 0.003 | acromegaly | NA | BeFree,GAD | Detail | |
| <0.001 | acute pancreatitis | However, local RAS regulate growth and inflammation in diverse cells and tissues... | BeFree | 24743610 | Detail |
| <0.001 | adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | adenoma | NA | BeFree | Detail | |
| <0.001 | Adrenal Gland Neoplasms | NA | BeFree | Detail | |
| 0.132 | Albuminuria | NA | CTD_human,GAD | Detail | |
| 0.003 | Alcoholic Intoxication, Chronic | NA | BeFree,GAD | Detail | |
| 0.120 | Alkalosis | NA | CTD_human | Detail | |
| 0.002 | Altitude Sickness | NA | GAD | Detail | |
| 0.006 | Alzheimer's disease | Angiotensin II (AngII) receptor blockers that bind selectively AngII type 1 (AT1... | BeFree,GAD | 24807206 | Detail |
| 0.006 | Alzheimer's disease | Ten of these genes, have previously been identified as candidate AD liability ge... | BeFree,GAD | 26028559 | Detail |
| 0.002 | amyotrophic lateral sclerosis | NA | GAD | Detail | |
| 0.002 | anaphylaxis | NA | GAD | Detail | |
| 0.120 | anemia | NA | CTD_human | Detail | |
| <0.001 | Cooley's anemia | NA | BeFree | Detail | |
| <0.001 | Anemia, Sickle Cell | NA | BeFree | Detail | |
| 0.004 | Aneurysm | Interestingly, in a model of enhanced vascular inflammation using angiotensin II... | BeFree | 25360548 | Detail |
| 0.004 | Aneurysm | Using microarray-based expression profiling of phorbol ester-stimulated THP-1 ce... | BeFree | 26113112 | Detail |
| 0.122 | Aneurysm, Dissecting | NA | CTD_human,GAD | Detail | |
| 0.006 | Angina, Unstable | NA | BeFree,GAD,LHGDN | Detail | |
| <0.001 | Fabry disease | NA | BeFree | Detail | |
| 0.120 | anuria | NA | CTD_human | Detail | |
| 0.001 | Anxiety Disorders | NA | BeFree | Detail | |
| 0.125 | aortic aneurysm | These results demonstrate that ACE2 exerts a modulatory role in AngII-induced AA... | BeFree,CTD_human | 25301841 | Detail |
| 0.125 | aortic aneurysm | Treatment with pharmacological Notch inhibitor (DAPT [N-(N-[3,5-difluorophenacet... | BeFree,CTD_human | 25349182 | Detail |
| 0.125 | aortic aneurysm | In early atherosclerotic lesions, Rgs1 regulates macrophage accumulation and is ... | BeFree,CTD_human | 25782711 | Detail |
| 0.125 | aortic aneurysm | Consistently, myeloid TM-deficient hyperlipidemic mice (ApoE(-/-)/LysMcre/TM(flo... | BeFree,CTD_human | 26338301 | Detail |
| <0.001 | Aortic Rupture | NA | BeFree | Detail | |
| <0.001 | aortic valve insufficiency | NA | BeFree | Detail | |
| 0.001 | aortic valve stenosis | NA | BeFree | Detail | |
| 0.120 | Cardiac arrhythmia | NA | CTD_human | Detail | |
| 0.012 | arteriosclerosis | Previous studies have reported important roles of endothelin-1 (ET-1) and angiot... | BeFree | 24877885 | Detail |
| 0.012 | arteriosclerosis | To investigate intercellular adhesion molecule-1 (ICAM1) and angiotensinogen (AG... | BeFree | 24942509 | Detail |
| 0.012 | arteriosclerosis | Interestingly, in a model of enhanced vascular inflammation using angiotensin II... | BeFree | 25360548 | Detail |
| 0.001 | asthma | NA | BeFree | Detail | |
| <0.001 | ataxia telangiectasia | NA | BeFree | Detail | |
| 0.241 | atherosclerosis | Previous studies have reported important roles of endothelin-1 (ET-1) and angiot... | BeFree,CTD_human,GAD,LHGDN,RGD | 24877885 | Detail |
| 0.241 | atherosclerosis | To investigate intercellular adhesion molecule-1 (ICAM1) and angiotensinogen (AG... | BeFree,CTD_human,GAD,LHGDN,RGD | 24942509 | Detail |
| 0.241 | atherosclerosis | Interestingly, in a model of enhanced vascular inflammation using angiotensin II... | BeFree,CTD_human,GAD,LHGDN,RGD | 25360548 | Detail |
| 0.016 | atrial fibrillation | NA | GAD,LHGDN | Detail | |
| 0.003 | bipolar disorder | NA | BeFree,GAD | Detail | |
| <0.001 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
| <0.001 | Brain Diseases | NA | BeFree | Detail | |
| 0.007 | Malignant neoplasm of breast | Association between AT1 and AT2 angiotensin II receptor expression with cell pro... | BeFree,GAD | 25682288 | Detail |
| <0.001 | Bronchial Spasm | NA | BeFree | Detail | |
| 0.002 | calcinosis | NA | GAD | Detail | |
| <0.001 | Malignant neoplasm of endometrium | The evaluation of involvement of angiotensin II, its receptors, and androgen rec... | BeFree | 25231075 | Detail |
| <0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
| <0.001 | renal cell carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This novel insight into the molecular mechanism underlying Ang-(1-7) and AngII interaction could pro... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The combination of Sox17 deficiency and angiotensin II infusion in mice induces vascular abnormaliti... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Role of two types of angiotensin II receptors in colorectal carcinoma progression. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Disease association analysis revealed that haplotype AGT influences CHD risk (OR 2.4, 95 % CI 1.23-4... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Renal function in angiotensinogen gene-mutated renal tubular dysgenesis with glomerular cysts. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Angiotensin II (Ang II), the major effector hormone of renin-angiotensin system, acts as a promoter ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Role of angiotensin II in experimental Venezuelan equine encephalitis in rats. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Angiotensin II, acting through its AT1 receptor, plays a critical role in generation of proteinuria ... | DisGeNET | Detail |
| DNA was extracted and tested for GAA mutations and some genetic polymorphisms able to influence musc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Furthermore, the AGT and GAC haplotypes were associated with a significantly higher prevalence of SS... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The M235T polymorphism in the angiotensinogen gene and heart failure: a meta-analysis. | DisGeNET | Detail |
| The angiotensinogen gene polymorphism is associated with heart failure among Asians. | DisGeNET | Detail |
| Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angioten... | DisGeNET | Detail |
| The M235T polymorphism in the angiotensinogen gene and heart failure: a meta-analysis. | DisGeNET | Detail |
| The angiotensinogen gene polymorphism is associated with heart failure among Asians. | DisGeNET | Detail |
| Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angioten... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| DNA vaccines have also been designed via a similar strategy using a plasmid vector encoding a hepati... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angioten... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The AGT-6A and 4072C alleles are associated with susceptibility to hypertension in this population. | DisGeNET | Detail |
| Gβ3-deficient mice were normal as judged by body weight gain by age or by feeding with high-fat diet... | DisGeNET | Detail |
| Increased association of hypertension and TT angiotensinogen gene polymorphism in patients with diab... | DisGeNET | Detail |
| In summary, PRO20 binds to both mouse and human PRRs and decreases angiotensin II formation and hype... | DisGeNET | Detail |
| Over-expression of copper/zinc superoxide dismutase in the median preoptic nucleus attenuates chroni... | DisGeNET | Detail |
| We isolated transgenic BMSCs (TG-BMSCs) from young end-organ-disease-free rats with increased RAS ac... | DisGeNET | Detail |
| The vaccine-induced anti-angiotensin II antibodies can efficiently ameliorate high blood pressure. | DisGeNET | Detail |
| The mechanism of hypertension-induced renal fibrosis is not well understood, although it is establis... | DisGeNET | Detail |
| AGT, ACE, and AT 1 R genes have overall effects with susceptibility to hypertension, where the SNPs ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Tailed allele-specific primers were designed to amplify by PCR six biallelic SNP loci [three in G pr... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The tissue concentrations of angiotensin II and gene expression of hypertrophic gene, myosin regulat... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Anterior wall infarction, increased leucocyte count, decreased longitudinal strain of left ventricul... | DisGeNET | Detail |
| The M235T polymorphism in the angiotensinogen gene and myocardial infarction risk: a meta-analysis. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Angiotensin II (Ang-II) is a bioactive peptide associated closely with the progression and metastasi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We evaluate whether angiotensinogen AGT M235T (rs699), angiotensin-converting enzyme ACE (I/D) (rs46... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Angiotensin II: immunohistochemical study in Sardinian pterygium. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| To evaluate the association between angiotensinogen (AGT) gene polymorphism and the risk of Henoch-S... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We isolated transgenic BMSCs (TG-BMSCs) from young end-organ-disease-free rats with increased RAS ac... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In addition to the CHADS2 score, angiotensinogen gene polymorphisms may be considered an additional ... | DisGeNET | Detail |
| The combination of Sox17 deficiency and angiotensin II infusion in mice induces vascular abnormaliti... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The relationship between angiotensinogen gene polymorphisms and essential hypertension in a Northern... | DisGeNET | Detail |
| Risk conferred by tagged SNPs of AGT gene in causing susceptibility to essential hypertension. | DisGeNET | Detail |
| The polymorphic angiotensinogen (AGT) gene is one of the most promising candidates for essential hyp... | DisGeNET | Detail |
| ACE I/D, AGT M235T, and ADD Gly460Trp polymorphisms are thought to be associated with primary hypert... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Clusterin/apolipoprotein J attenuates angiotensin II-induced renal fibrosis. | DisGeNET | Detail |
| The mechanism of hypertension-induced renal fibrosis is not well understood, although it is establis... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We evaluate whether angiotensinogen AGT M235T (rs699), angiotensin-converting enzyme ACE (I/D) (rs46... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We suggest that RAS gene polymorphisms (ACE-I/D, AGT M235T) are significantly associated with suscep... | DisGeNET | Detail |
| Left ventricular remodelling after acute myocardial infarction: impact of clinical, echocardiographi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal... | DisGeNET | Detail |
| Peroxisome proliferator-activated receptor x03B3; agonists have been shown to inhibit angiotensin II... | DisGeNET | Detail |
| Using a loss-of-function genetic mouse model, we demonstrated that the lack of Mmp17 resulted in the... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genotyping of the angiotensinogen gene is helpful to determine which AF patients may benefit from tr... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genetic Association Between Angiotensinogen Polymorphisms and Lung Cancer Risk. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Homozygous deletion of Opg in apolipoprotein E-deficient mice (ApoE(-/-)Opg(-/-)) inhibited angioten... | DisGeNET | Detail |
| Renal function in angiotensinogen gene-mutated renal tubular dysgenesis with glomerular cysts. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The results showed that the distribution of AGT and REN polymorphisms were similar in patients with ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Four polymorphisms, located in the ACE (rs4291), angiotensinogen (rs5049) and (pro)renin receptor (r... | DisGeNET | Detail |
| Four polymorphisms, located in the ACE (rs4291), angiotensinogen (rs5049) and (pro)renin receptor (r... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In early atherosclerotic lesions, Rgs1 regulates macrophage accumulation and is required for the for... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| DNA was extracted and tested for GAA mutations and some genetic polymorphisms able to influence musc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The evaluation of involvement of angiotensin II, its receptors, and androgen receptor in endometrial... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Accumulating evidence suggests a role for angiotensin-converting enzymes involving the angiotensin I... | DisGeNET | Detail |
| Taken together with our previous data which indicate that pro-inflammatory processes in the paravent... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angio... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genetic Association Between Angiotensinogen Polymorphisms and Lung Cancer Risk. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| To investigate intercellular adhesion molecule-1 (ICAM1) and angiotensinogen (AGT) gene polymorphism... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Effects of endogenous myeloperoxidase on CA formation and rupture were studied in myeloperoxidase kn... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Interestingly, in a model of enhanced vascular inflammation using angiotensin II, P2Y(6) deficiency ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We enrolled 109 consecutive patients with left ventricular systolic dysfunction [left ventricular ej... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Angiotensin II (Ang-II) is a bioactive peptide associated closely with the progression and metastasi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The evaluation of involvement of angiotensin II, its receptors, and androgen receptor in endometrial... | DisGeNET | Detail |
| The aim of the present study was to evaluate the role of AGT and REN gene polymorphisms as susceptib... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In experimental mouse models, infection with highly pathogenic avian influenza A H5N1 virus results ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| According to the analysis of the three strong positive SNPs, the haplotype of AGT increased signific... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| To test our hypothesis, we used an angiotensin II infusion model of hypertensive chronic kidney dise... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| However, local RAS regulate growth and inflammation in diverse cells and tissues, and their activity... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Angiotensin II (AngII) receptor blockers that bind selectively AngII type 1 (AT1) receptors may prot... | DisGeNET | Detail |
| Ten of these genes, have previously been identified as candidate AD liability genes in genetic assoc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Interestingly, in a model of enhanced vascular inflammation using angiotensin II, P2Y(6) deficiency ... | DisGeNET | Detail |
| Using microarray-based expression profiling of phorbol ester-stimulated THP-1 cells, we found that a... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| These results demonstrate that ACE2 exerts a modulatory role in AngII-induced AAA formation, and tha... | DisGeNET | Detail |
| Treatment with pharmacological Notch inhibitor (DAPT [N-(N-[3,5-difluorophenacetyl]-L-alanyl)-S-phen... | DisGeNET | Detail |
| In early atherosclerotic lesions, Rgs1 regulates macrophage accumulation and is required for the for... | DisGeNET | Detail |
| Consistently, myeloid TM-deficient hyperlipidemic mice (ApoE(-/-)/LysMcre/TM(flox/flox)) were resist... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Previous studies have reported important roles of endothelin-1 (ET-1) and angiotensin II (Ang II) in... | DisGeNET | Detail |
| To investigate intercellular adhesion molecule-1 (ICAM1) and angiotensinogen (AGT) gene polymorphism... | DisGeNET | Detail |
| Interestingly, in a model of enhanced vascular inflammation using angiotensin II, P2Y(6) deficiency ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Previous studies have reported important roles of endothelin-1 (ET-1) and angiotensin II (Ang II) in... | DisGeNET | Detail |
| To investigate intercellular adhesion molecule-1 (ICAM1) and angiotensinogen (AGT) gene polymorphism... | DisGeNET | Detail |
| Interestingly, in a model of enhanced vascular inflammation using angiotensin II, P2Y(6) deficiency ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angio... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The evaluation of involvement of angiotensin II, its receptors, and androgen receptor in endometrial... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386511346 dbSNP
- Genome
- hg19
- Position
- chr1:230,826,522-230,881,322
- Variant Type
- snv
Genome browser